Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development

• Rui Li,
• Morgan Craig,
• Morgan Craig,
• David Z. D'Argenio,
• Alison Betts,
• Donald E. Mager,
• Donald E. Mager,
• Tristan S. Maurer

Affiliations

Rui Li

Translational Modeling and Simulation, Medicine Design, Pfizer Inc., Cambridge, MA, United States

Morgan Craig

Department of Mathematics and Statistics, Université de Montréal, Montréal, QC, Canada

Morgan Craig

Sainte-Justine University Hospital Research Centre, Montréal, QC, Canada

David Z. D'Argenio

Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, United States

Alison Betts

Applied BioMath, LLC, Concord, MA, United States

Donald E. Mager

Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States

Donald E. Mager

Enhanced Pharmacodynamics, LLC, Buffalo, NY, United States

Tristan S. Maurer

Translational Modeling and Simulation, Medicine Design, Pfizer Inc., Cambridge, MA, United States